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ABSTRACT
Solubility, structure and position of char-
ges in a peptide antigen sequence can be
mentioned as being amongst the basic fea-
tures of adsorption. In order to study their
effect on adsorption, seven analogue se-
ries were synthesized from a MSP-1 pepti-
de sequence by systematically replacing
each one of the positions in the peptide se-
quence by aspartic acid, glutamic acid, se-
rine, alanine, asparagine, glutamine or
lysine. Such modifications in analogue
peptide sequences showed a non-regular
tendency regarding solubility and adsorp-
tion data. Aspartic acid and Glutamic acid
analogue series showed great improve-
ments in adsorption, especially in peptides
where Lysine in position 6 and Arginine in
position 13 were replaced. Solubility of
position 5 analogue was greater than the
position 6 analogue in Aspartic acid series;
however, the position 6 analogue showed
best adsorption results whilst the Aspartic
acid in position 5 analogue showed no ad-
sorption in the same conditions. Nuclear
Magnetic Resonance structural analysis
revealed differences in the -helical structu-
re extension between these analogues. The
Aspartic acid in position 6, located in the
polar side of the helix, may allow this ana-
logue to fit better onto the adsorption re-
gions suggesting that the local electrostatic
charge is responsible for this behavior.
Key words: Adsorption, aluminium
hydroxide, peptide analogues, solubility
and adsorption, structure and adsorption,
charge position and adsorption.
RESUMEN
La solubilidad, la estructura y la posición
de cargas en una secuencia de un péptido
antígeno, se encuentran entre las caracte-
rísticas básicas de la adsorción. Con el fin
de estudiar su efecto sobre la adsorción,
fueron sintetizadas siete series de análo-
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gos de la secuencia de un péptido de la
proteína MSP-1, reemplazando sistemáti-
camente cada una de las posiciones en la
secuencia del péptido por ácido aspártico,
ácido glutámico, serina, alanina, aspara-
gina, glutamina o lisina. Las modificacio-
nes en las secuencias de los péptidos aná-
logos no mostraron tendencias regulares
respecto a los datos de solubilidad y ad-
sorción. Las series de análogos de ácido
aspártico y ácido glutámico presentaron
grandes incrementos en la absorción, en
especial cuando fueron reemplazadas la
lisina de la posición 6 y la arginina de la
posición 13. La solubilidad del análogo
en posición 5 fue mayor que la del análo-
go en posición 6 en la serie del ácido as-
pártico; sin embargo, los mejores resulta-
dos en adsorción se obtuvieron al sustituir
con ácido aspártico la posición 6, mien-
tras que el análogo con el ácido aspártico
en la posición 5 no presentó adsorción a
las mismas condiciones. El análisis es-
tructural por resonancia magnética nu-
clear mostró diferencias en la extensión
de la estructura -helical entre estos análo-
gos. El ácido aspártico en la posición 6,
localizado en la cara polar de la hélice,
podría permitir a este análogo ajustarse
mejor sobre los sitios de adsorción, sugi-
riendo que la carga electrostática local es
la responsable de este comportamiento.
Palabras clave: adsorción, hidróxido
de aluminio, péptidos análogos, solubili-
dad y adsorción, estructura y adsorción,
posición de carga y adsorción.
INTRODUCTION
Aluminium-containing adjuvants have
been widely used because of their safety
in humans and are currently the only ones
being included in vaccines. Aluminium
hydroxide or aluminium phosphate is
commonly used as adsorbent for anti-
gens. Hem et al have done a lot of exce-
llent work during the last few decades on
these adsorbents’ chemical structure and
the conditions for protein adsorption
(1-5). The aluminium hydroxide adjuvant
used in vaccines has been identified as
boehmite, a crystalline aluminium
oxyhydroxide, and the aluminium phosp-
hate as amorphous aluminium hydroxy-
phosphate (6). These gels’ properties
(such as surface area, surface charge,
chemical composition and chemical
structure) depend very strongly upon the
production process (7).
One goal in formulating and manufac-
turing vaccines containing aluminium
hydroxide or aluminium phosphate is for
the adjuvant to adsorb the antigen. Alu-
minium hydroxide adsorbing proteins has
been neglected, even though alumi-
nium-containing adjuvant has been used
in vaccines for decades. Electrostatic at-
traction, hydrophobic attraction and li-
gand exchange represent the major me-
chanisms responsible for aluminium-
containing adjuvants adsorbing antigens
(4-6). Electrostatic attraction is the most
frequently encountered adsorption me-
chanism, as both antigens and adjuvants
have a pH-dependent surface charge.
Knowing the antigen and adjuvant pI, as
well as the pH, allows to predict the de-
gree of adsorption that will occur when
vaccines are prepared (1, 3). However,
examining pI and pH values may not be
useful in predicting a complete vaccine’s
physical properties (8). Physical proper-
ties will likely depend on the antigen-ad-
juvant complex’s surface charge charac-
teristics.
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Optimum formulation of vaccines con-
taining multivalent antigens may require
more than a simple type of alumi-
nium-containing adjuvant. A positively
charged adjuvant such as aluminium
hydroxide can be used (1, 3) to maximize
negatively charged antigen binding in
some cases; a negatively charged adju-
vant such as aluminium phosphate might
be preferred in others if the antigen were
positively charged (1, 9). The multivalent
vaccine would therefore be prepared by
combining individual monovalent bulks
resulting in a suspension consisting of mi-
xed aluminium-containing adjuvants (8).
Questions arise regarding the potential
for redistributing antigens and adsorbed
phosphate anions as well as multivalent
vaccine colloidal stability using different
aluminium-containing adjuvants.
Many factors may influence the physi-
cochemical antigen adsorption process in
producing adsorbed vaccines. It has thus
become necessary to develop new designs
for introducing combined vaccines, and
besides there are a lot of as yet unknown
or not understood immunological interac-
tions between these vaccine components.
In this work, seven analogues series
were synthesized from a well known pep-
tide sequence (10) by serially replacing
each of the amino acids in the target se-
quence by aspartic acid (Asp), glutamic
acid (Glu), serine (Ser), alanine (Ala), as-
paragine (Asn), glutamine (Gln) or lysine
(Lys). Solubility and adsorption onto alu-
minium hydroxide were tested for each of
the analogue series. No correlation was
found between solubility and adsorption.
Asp and Glu analogue series showed
great improvements in adsorption, espe-
cially in peptides where Lysine in posi-
tion 6 and Arginine in position 13 were re-
placed. The Asp-5 analogue’s solubility
(analogue where the position 5 was repla-
ced by Asp) was greater than the Asp-6
analogue (analogue where the position 6
was replaced by Asp); however, the Asp-6
peptide showed the best results in the ad-
sorption test. CD and NMR structural
analysis revealed no significant structural
differences between these analogues, sug-
gesting that the local electrostatic charge is
responsible for this behavior.
MATERIALS AND METHODS
Analogue series design and peptide
synthesis
Based on the malarial MSP-1 protein
1585 peptide sequence (EVLYLKPLA
GVYRSLKKQLE), sets of peptides were
designed by replacing each one of the 20
amino acids in the sequence by Asp (D),
Glu (E), Asn (N), Gln (Q), Lys (K), Ser
(S) or Ala (A). A total of seven peptide
analogue series were obtained. Table 1
shows the Asp analogue set of peptides as
an example. The same procedure was fo-
llowed for the Glu, Asn, Gln, Lys, Ser or
Ala analogue sets of peptides.
Peptide 1585 and its 20-mer peptide
analogues were synthesized by using
standard t-boc solid phase peptide synthe-
sis (SPPS) (11) and crude peptides puri-
fied by RP-HPLC on a 218TP1022
Vydac column. Peptide purity was veri-
fied by RP-HPLC on an analytical Lich-
rosorb C18 (MERCK) using a 0%-70% B
gradient over 30 minutes. Solvent A was
0.05% TFA in water and solvent B was
0.05% TFA in acetonitrile. The pro-
ducts’ molecular mass was determined by
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using a Bruker Protein Maldi-TOF mass
spectrometer.
Solubility assays
Peptide solubility was determined by sa-
turating 1 mL 0.9% saline solution at 25
ºC, 7±0.1 pH. Dissolved peptide was
measured by Multicelda Labsystem spec-
trophotometer using micro-bicinchoninic
acid protein assay procedure (Pierce)
(12). The standard protocol was used and
calibration curves drawn for each peptide
analogue.
Adsorption
Equilibrium time for peptide 1585 ad-
sorption on aluminium hydroxide was de-
termined by preparing 12 samples of a 4
mg/mL peptide solution in 0.9% NaCl,
7±0.1 pH. An aluminium hydroxide
aqueous suspension (ALHIDROGEL)
was added to each sample in quantities
equivalent to 1.6 mg Al/mL (13), keeping
the temperature constant at 273 K. The
resulting mixtures were gently shaken at
150 rpm during the whole experiment.
Samples were taken each 10 minutes du-
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Table 1. Sequences for Aspartic peptide analogue series. This series was designed by
serially replacing each of the amino acids in the target sequence by aspartic acid (Asp)
ring the first hour and then each hour until
6 hours had been completed to evaluate
adsorption regarding time. The samples
were spun at 8,000 rpm and filtered
through 0.22µm membrane to determine
peptide concentration before and after ad-
sorption using bicinchoninic acid (BCA),
as indicated in the solubility test. The
quantity adsorbed was established in
mmol/mg Al by the difference between
these two concentrations.
Adsorption experiments for different
analogue series were done in the already
described conditions by shaking the mix-
ture at 273 K for 30 minutes in a helicoi-
dal agitator. Adsorption isotherms were
established using concentrations of each
peptide ranging from 0 to 3.2 mmol/mL
in 0.9% NaCl, 7±0.1 pH and 273 K.
Each sample contained a quantity of adju-
vant equivalent to 1.6 mg Al/mL. Known
amounts of peptide analogue and alumi-
nium hydroxide were mixed in an
end-over-end rotator for 30 minutes. The
mixtures were then centrifuged and the
protein concentration in the clear super-
natant was measured by Multicelda
Labsystem spectrophotometer using the
micro-bicinchoninic acid protein assay
procedure (Pierce) (12). The amount of
adsorbed protein was determined from
the difference between the peptide con-
centrations in solution before and after
adsorption. The amount of peptide adsor-
bed per unit area of adsorbent surface was
plotted against the peptide concentration
in solution, following adsorption.
NMR spectroscopy
Samples for all NMR experiments were
prepared by dissolving 8 mg peptide in
500 ìL TFE-d3/H2O mixture (30/70
(v/v)). A BRUKER DRX-600 spectro-
meter was used to obtain 1H NMR spec-
tra. Proton spectra were assigned by
using double-quantum filter COSY
(DQF-COSY) and TOCSY experiments.
Interproton NOEs were determined by
phase-sensitive NOESY. A mixing time
ranging from 200 to 600 ms was used for
the NOESY experiment.
These data were processed on an Indy
computer (Silicon Graphics) equipped with
XWINNMR software update. All experi-
ments were performed at 295 K (except for
temperature-dependent experiments) and
water signal was suppressed by using
Noesy Pr1D. All chemical shifts were refe-
renced to a 4.45 ppm water peak.
Temperature coefficients
NH proton temperature coefficients were
determined over a 285-315 K temperature
range. Chemical shift varied linearly with
temperature in all protons; temperature
coefficients were determined as being the
gradient of chemical shift function depen-
dence over temperature (-ÄäHN/ÄT).
Structure calculations
The distance geometry (DGII) program
(MSI) was used to generate 50 starting
structures. NOE intensities, used as input
for the structure calculations, were obtai-
ned from a NOESY spectrum recorded at
295 K with 400 ms mixing time. NOEs
were partitioned into strong, medium and
weak categories and then converted into
distance restraints (1.8-2.8, 2.8-3.5 and
3.5-5.0 Å). Pseudo-atoms were used where
diastereotopic protons could not be distin-
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guished from each other and the correspon-
ding corrections for restraints involving
pseudo-atoms were applied. Hydrogen
bond constrains were introduced for the low
amide temperature coefficients; only < 3.5
-ÄäHN/ÄT ppb/K were used in structure cal-
culations. Distance ranges involving this li-
kely hydrogen-bound NHi…..Oi-4 were set
at 1.8-2.5 Å.
The structures from DGII were refined
using restrained simulated annealing (SA)
software (Discover). All peptides were
forced to trans and Cá chirality’s to L du-
ring the calculations.
The final representative family of low-
energy conformers satisfying the set of
experimental distance restraints was de-
termined by the energy and root mean
square clustering method.
RESULTS AND DISCUSSION
Solubility of peptide 1585-analogue
series
Figure 1 shows the solubility data for se-
ven different analogue series. A general
overview of the Asp-analogue series (Fi-
gure 1A) showed decreasing solubility
values regarding the native sequence
(peptide 1585). Nevertheless, positions 3
(Leu), 6 (Lys), 9 (Ala), 16 (Lys) and 17
(Lys) were critical. Each of these amino
acids was replaced by Asp but there was
no correlation between charge, size or
polarity and decreasing solubility trend.
The serine-analogue series (Figure 1F)
showed similar behaviour to the aspar-
tic-analogue series, with some differen-
ces in critical position. In this case, 3 out
of the 5 critical positions were similar
(positions 6, 16, 17), having 2 new criti-
cal positions, 7 (Pro) and 15 (Leu).
Asn-analogue series (Figure 1C) sho-
wed increasing solubility, except in posi-
tion 9 (Ala), 17 (Lys) and 18 (Gln), which
were the critical positions. Glu and Gln
solubility data were similar. There were
only two common critical positions in so-
lubility test for all the analogue series: 16
(Lys) and 17 (Lys). The Lysine-analogue
series presented unexpected behaviour. It
was supposed that substituting a hydrop-
hobic amino acid such as Val or Leu in a
peptide’s sequence would increase its so-
lubility a lot. This increasing solubility
value only occurred when valine was re-
placed (Lys-2 and Lys-11 peptide analo-
gues), but was not so in leucine (Lys-3,
-5, -8, -15 and -19 peptide analogues).
This unexpected result was observed for
leucine replacement in all the analogue




The lysine-analogue series (Figure
2G) was designed as a negative control
since rejection was expected between alu-
minium hydroxide and positively charged
peptides. There was agreement between
expected and found results. Lys substitu-
tion in position 6 by any other amino acid
in all the analogue series (Figures 2A to
2F) gave an increasing value for the
amount of peptide adsorbed onto the alu-
minium hydroxide. The same behaviour
was found for arginine in position 13 (Fi-
gures 2A to 2F), but in lesser proportion.
Very low solubility was found when lysi-
ne was replaced in positions 16 and 17 in
the Asp-, Glu-, Ala- and Ser-analogue se-
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Figure 1. Solubility of the different analogue series in 0.9% NaCl at pH 7  0.1, 298 K.
ries, so it was not possible to analyse the
adsorption for those analogue peptides
(Figures 2A, 2B, 2E, 2F). Almost all the
analogues decreased their adsorption res-
pecting reference peptide 1585, except in
position 6 where lysine was replaced by
Asp, Glu, Ser, Asn, Gln, or Ala.
Irregular analogue peptide behaviour
was observed in all series, the fact that
positive Lys charge in position 6 was rele-
vant in the adsorption process onto alumi-
nium and that adsorption increased when
Lys serially replaced the amino acids in
this series’ sequence indicated that these
peptides adsorption onto aluminium
hydroxide was predominantly guided by
electrostatic effects.
Larger adsorption was shown in all
analogues peptides series where Lys (6)
and Arg (13) had been replaced. The lar-
gest increase in adsorption was shown
with the Asp-6 analogue (Lys in position
6 was replaced by Asp) peptide.
In view of the physicochemical simila-
rity, having the same charge and a light
structural difference, it can be expected
that aspartic and glutamic amino acids af-
fect in similar way the behavior of pepti-
des. Nevertheless, glutamic acid gives
analogue peptides with smaller adsorp-
tion capacity than the corresponding as-
partic acid analogues. It can be explained
because of the larger mass and volume of
glutamic acid which generates a decrease
in load density with regard to that of as-
partic acid, in order to compensate for the
revolting effect of the positively loaded
residues. Furthermore, changes in che-
mical nature of adsorption site and in ana-
logue structure should be considered
which can influence an appropriate orien-
tation of the molecule toward the adsor-
bent surface. Position 3 analogues, where
the adsorption increase, had the opposite
effect possibly because of glutamic acid
compensates part of the lysine load in po-
sition 6, as already was established, is de-
terminant for the adsorption on alumi-
nium hydroxide.
The Asp-6 analogue peptide (having
better adsorption) and the Asp-5 analogue
(having very low adsorption) were cho-
sen as positive and negative controls for
NMR structural analysis.
NMR studies
The 1H chemical shifts were assigned ac-
cording to Wüthrich’s standard strategy
(14). TOCSY and DQF-COSY spectra
were used for correlating side-chain spin
system with HN-CHá cross-peaks. The
amino acids were sequence-specific lin-
ked by using CHá-HN, CHâ-HN or
NH-HN space connectivity obtained
from NOESY spectra.
Structure determination
Medium-strength signals were found bet-
ween spatial neighbours, such as dNN(i,
i+1), dáN(i, i+3), dáN(i, i+4), dáâ(i, i+3)
(Figure 3), suggesting the presence of a
region having a helical tendency between
residues 5L and 19L for Asp-5 analogue
peptide and between 6K and 19L for Asp-6
analogue peptide.
Amide proton temperature coeffi-
cients less than 4.5 ppb/K presented ex-
tremely slow exchange with solvent
hydrogen and were possibly involved in
hydrogen bonds. Asp-5 analogue peptide
presented coefficients of less than 4.5
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Figure 2. Adsorption onto aluminum hydroxide of the different analogue series in 0.9% NaCl at pH 7  0.1
and 298 K.
* No available
ppb/K in residues 12Y, 13R, 15L and 16K
and Asp-6 analogue peptide in 12Y, 13R,
15L and 17K residues (Figure 3). This con-
firmed that the peptide had adopted an
á-helix structure.
Table 2 shows that 26 out of the 50 re-
sulting structures chosen for Asp-5 analo-
gue peptide did not present distance viola-
tions greater than 0.35 Å or ù angles
greater than 1.70°. An average RMSD for
main-chain atoms equal to 0.27 Å was ob-
tained by superimposing the structures
between amino acids 5L and 19L resulting
in a consensus structure having the least
total energy. 24 out of the 50 resulting
structures for Asp-6 analogue peptide
were chosen which did not present distan-
ce violations greater than 0.29 Å or ù an-
gles greater than 1.20°. An RMSD value
equal to 0.24 Å was obtained by superim-
posing the structures between amino acids
6K and 19L. Kabasch and Sander’s analysis
of these peptides showed an á-helix struc-
ture between residues 5L and 19L for Asp-5
analogue peptide and between residues 6K
and 19Lfor Asp-6 analogue peptide (Figure
4). The amino terminal regions were flexi-
ble in both peptides.
In summary, the unusual up and down
values in solubility and adsorption data sug-
gested that there were no regular tendency
in the analogue series. No correlations bet-
ween solubility and adsorption data were
found. NMR analysis revealed differences
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Figure 3. Summary of sequential medium range NOE connectivity (NOE intensities are represented by the line
thickness), amide protons having low coefficients used for structure calculations are marked with ().
Table 2. Results of peptide structure calculations
in the -helical structure extension between
these analogues. In Asp-5 analogue peptide
the -helical structure extends from residue 5
to 19 and in Asp-6 analogue peptide from
residue 6 to 19. In analogue Asp-5 (sho-
wing very low adsorption), the Aspartic
acid is located in the hydrophobic face of
the helix, while in analogue Asp-6 (sho-
wing maximum adsorption) the Aspartic
acid is in the hydrophilic side. The fact that
the Aspartic acid in position 6 is located in
the polar side of the helix, may allow this
analogue to fit better onto the adsorption re-
gions. The fact that positive Lys charge in
position 6 was relevant in the adsorption
process onto aluminium hydroxide and the
decreasing adsorption values in the lysine
series indicated that these peptides’ adsorp-
tion onto aluminium hydroxide was predo-
minantly guided by electrostatic effects.
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